Keynote – AI and Genomics Powered Modern Pathology is the Engine of Precision Medicine
Marilyn M. Bui, MD, PhD, Scientific Director, Analytic Microscopy Core; Section Head, Bone & Soft Tissue Pathology, Moffitt Cancer Center (Tampa, FL) ; Professor & Program Director, Cytopathology, University of South Florida Morsani College of Medicine
Digital pathology (DP) and AI are the 3rd revolution in pathology marked by the milestones including the 1st digital scanner cleared by the FDA for primary diagnosis in 2017, the AI pathology solutions released in 2018, and the remote sign-out in routine practice using whole slide images during COVID19 pandemic. Biomarker testing, largely done by pathology and laboratory medicine, provides diagnostic, prognostic and predictive information to direct the delivery of precision medicine (PM). With the combined power of genomics and AI, pathology and laboratory medicine will transform and optimize the quality, efficiency and value of PM. This talk will illustrate the potential of DP/AI in PM, discuss the challenges in DP/AI development and implementation, highlight examples of good practice and resources, emphasize the importance of embracing DP/AI by pathologists, and call for collaboration of the medical and scientific community in the digital health revolution to ultimately benefit patient care.